Listing 1 - 10 of 152 << page
of 16
>>
Sort by

Book
Fiches d'économie de la santé : rappels de cours et exercices corrigés
Author:
ISBN: 9782340026568 2340026563 Year: 2018 Publisher: Paris: Ellipses,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Le financement de l'activité hospitalière en Belgique : contexte, situation actuelle et perspectives
Author:
ISBN: 2804724220 Year: 2022 Publisher: Bruxelles : Pierre Mardaga Editeur,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Dissertation
Analyse de la relation d'interdépendance entre qualité du leadership et niveau de résilience organisationnelle en milieu hospitalier
Authors: --- --- ---
Year: 2018 Publisher: Liège Université de Liège (ULiège)

Loading...
Export citation

Choose an application

Bookmark

Abstract

Nowadays, the realm of safety management is moving from former reactive to more proactive approaches. Consequently, organizational resilience is increasingly regarded as a relevant way to manage performance and safety in many types of organizations. This concept promotes 4 cornerstones to do so: anticipating, monitoring, responding and learning.&#13;However, these competences require a tremendous continual commitment from all staff and stakeholders. The power of influence that some leaders can have on their teams and colleagues might become an explanatory variable of the level of organizational resilience witnessed in all kinds of institutions.&#13;This study takes place in healthcare organizations and focuses on two variables: the quality of the leadership expressed by the heads of medical services and the level of organizational resilience preventing these departments from failure.&#13;This master’s thesis starts with an overview of published literature on leadership and organizational resilience. The two concepts were first defined and afterwards put into the context of healthcare management. Several tools were then explored and chosen to build a relevant questionnaire in order to lead empirical research in several medical departments. The second part of this thesis is dedicated to the aforementioned comparative study. We led our research by meeting with the heads of 10 different medical departments. These qualitative interviews provided us with valuable information about the way the chief medical officers lead their services and the abilities of those to anticipate and monitor risks, respond to unexpected situations and learn from the past.&#13;These empirical results allowed us to identify a resilience profile for each of the visited departments and to assess the quality of the leadership in each of those. Moreover, it enabled us to make clear comparisons between them and to highlight the best practices.&#13;Finally, based on our quantitative assessments, we investigated a hypothetical correlation relation between the quality of the leadership and the level of organizational resilience.


Book
Le cannabis médical comme traitement adjuvant des chimiothérapies : réalité thérapeutique ou effet de mode ?
Authors: --- ---
Year: 2018 Publisher: Bruxelles: UCL. Faculté de pharmacie et des sciences biomédicales,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Nowadays, the controversial issue of medical cannabis is getting more and more attention by numerous health professionals who decide to study the subject. Among the various components of Cannabis Sativa, two main phytocannabinoids stand out from a therapeutic point of view: on the hand Δ9-THC for its analgesic, myorelaxant, antiemetic and orexigenic action and on the other hand cannabidiol for its antiemetic, anxiolytic, neuroprotective, antiepileptic’s and anti-inflammatories properties. Those two compounds act on the endocannabinoid system mediated by cannabinoid receptors CB1 and CB2. However, the attractive properties of medical cannabis are counterbalanced by the significant appearance of psychoactive and cognitive side effects as well as by the development of an addition. Considering the current state of knowledge and therapeutic alternatives now on the market, does medical cannabis constitute a real therapeutic interest for the treatment of nausea and vomiting or for anorexia associated with weight loss among patients undergoing chemotherapy ? La question complexe du cannabis médical est un sujet majeur auquel de nombreux professionnels de la santé s’intéressent actuellement. Parmi les multiples composant du Cannabis Sativa, deux phytocannabinoïdes principaux retiennent l’attention d’un point de vue thérapeutique : premièrement le Δ9-THC pour son action analgésique, myorelaxante, antiémétique et orexigène et ensuite le cannabidiol pour ses propriétés antiémétiques, anxiolytiques, neuroprotectrices, antiépileptiques et anti-inflammatoires. Ceux-ci agissent au niveau du système endocannabinoïde médié par les récepteurs aux cannabinoïdes CB1 et CB2. Les propriétés intéressantes du cannabis médical sont cependant contrebalancées par l’apparition importante d’effets secondaires psychoactifs et cognitifs ainsi que par le développement d’une dépendance. Au vu de l’état des connaissances actuelles et des alternatives thérapeutiques dans le traitement des nausées et vomissement ainsi que dans l’anorexie associée à une perte de poids chez les patients sous chimiothérapie ?


Book
Zones à défendre : manuel d'autodéfense féministe dans le cadre de la consultation en santé sexuelle et reproductive
Authors: --- --- --- --- --- et al.
Year: 2020 Publisher: Bruxelles Femmes et Santé

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Evaluation médicale des soins hospitaliers
Authors: ---
ISBN: 2717823352 9782717823356 Year: 1992 Volume: vol *2 Publisher: Paris Economica

Loading...
Export citation

Choose an application

Bookmark

Abstract

Keywords

Quality of Health Care --- Health Care Evaluation Mechanisms --- Quality Assurance, Health Care. --- Program Evaluation. --- Hospital Administration. --- Administration, Hospital --- Hospital Organization and Administration --- Organization and Administration, Hospital --- Hospitals --- Family Planning Program Evaluation --- Program Appropriateness --- Program Effectiveness --- Program Sustainability --- Evaluation, Program --- Appropriateness, Program --- Effectiveness, Program --- Evaluations, Program --- Program Evaluations --- Program Sustainabilities --- Sustainabilities, Program --- Sustainability, Program --- Evaluation Studies as Topic --- Social Validity, Research --- Health Care Quality Assessment --- Health Care Quality Assurance --- Healthcare Quality Assessment --- Healthcare Quality Assurance --- Quality Assessment, Healthcare --- Quality Assurance, Healthcare --- Quality Assessment, Health Care --- Assessment, Healthcare Quality --- Assessments, Healthcare Quality --- Assurance, Healthcare Quality --- Assurances, Healthcare Quality --- Healthcare Quality Assessments --- Healthcare Quality Assurances --- Quality Assessments, Healthcare --- Quality Assurances, Healthcare --- organization & administration --- France. --- Miquelon and Saint Pierre --- Miquelon and St. Pierre --- St. Pierre and Miquelon --- Corsica --- Saint Pierre and Miquelon --- Hospital care --- France --- Medical care --- Evaluation --- Quality Assurance, Health Care --- Program Evaluation --- Hospital Administration


Book
Réduire les inégalités sociales en santé
Authors: --- --- ---
ISBN: 9782916192239 Year: 2010 Publisher: Saint-Denis : Institut national de prévention et d’éducation pour la santé


Book
Les soins de santé primaires dans les pays industrialisés : rapport sur une réunion de l'OMS, Bordeaux, 14-18 novembre 1983
Author:
ISBN: 9289022612 Year: 1986 Volume: vol 95

Loading...
Export citation

Choose an application

Bookmark

Abstract


Dissertation
Evaluation des fournisseurs dans le département de physique médicale afin de maîtriser les risques et les opportunités
Authors: --- --- --- ---
Year: 2017 Publisher: Liège Université de Liège (ULiège)

Loading...
Export citation

Choose an application

Bookmark

Abstract

In this paper, I firstly offer a description of the problems that the department of medical physics from the CHU of Liège is currently facing due to the lack of suppliers monitoring. I believe this leads to a higher risk of receiving a poor maintenance on the machines, which would impact their availability and hence disturb both users and patients.&#13;I then proceed to detail how I, through scientific research and the benchmark of another department, have come up with a linear-weighted model based on SMART and objective key performance indicators to help solve this issue. I then explain that those KPIs were created based on the existing service contracts with the suppliers and the expectations of the department. In order to improve the practicality and efficiency of this new task, I offer an alternative control method based on subjective attributes in addition with an automatic model to compute the indicators.&#13;Thirdly, with the intention to comply with the quality norms ISO9001, I map the processes and add procedures to demonstrate who does what, when and how so that the manager clearly knows how to use the tools. Furthermore, I provide the hospital with my risk analysis regarding the implementation phase of the tools. I highlight several risks by adopting a project management methodology and I propose solutions to reduce the identified and prioritized risks. I evaluate the effectiveness of my solutions on the risks and I estimate no risk to still be above the acceptable level assuming the application of my ideas. I go on by justifying the adequacy of my methodology with the training on project management from the ESQ UQAM. In this chapter, I also take a step back on my work and attempt to criticize my approach.&#13;I end this paper with my recommendations for the short and long-term efficiency of my tools. If they wish to obtain a precise control tool, I highly encourage the department to work on the quality of the existing data base by communicating with its staff and by collaborating with its suppliers. I submit a priority list of the suppliers for the department to begin the evaluation and I strongly advocate the manager to analyze and take appropriate actions within a maximum of 6 months after the evaluation of the supplier. I conclude with the possibility of integrating SLAs and criticality in the future specifications.

Listing 1 - 10 of 152 << page
of 16
>>
Sort by